- Home
- EARN vs TVGN Comparison
EARN vs TVGN Comparison
Compare EARN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EARN
- TVGN
- Stock Information
- Founded
- EARN 2012
- TVGN 2020
- Country
- EARN United States
- TVGN United States
- Employees
- EARN N/A
- TVGN N/A
- Industry
- EARN Real Estate Investment Trusts
- TVGN Blank Checks
- Sector
- EARN Real Estate
- TVGN Finance
- Exchange
- EARN Nasdaq
- TVGN Nasdaq
- Market Cap
- EARN 187.6M
- TVGN 174.4M
- IPO Year
- EARN 2013
- TVGN N/A
- Fundamental
- Price
- EARN $6.60
- TVGN $1.43
- Analyst Decision
- EARN Hold
- TVGN
- Analyst Count
- EARN 1
- TVGN 0
- Target Price
- EARN N/A
- TVGN N/A
- AVG Volume (30 Days)
- EARN 639.2K
- TVGN 4.9M
- Earning Date
- EARN 03-05-2025
- TVGN 02-20-2025
- Dividend Yield
- EARN 14.53%
- TVGN N/A
- EPS Growth
- EARN 277.67
- TVGN N/A
- EPS
- EARN 1.02
- TVGN N/A
- Revenue
- EARN N/A
- TVGN N/A
- Revenue This Year
- EARN N/A
- TVGN N/A
- Revenue Next Year
- EARN $89.08
- TVGN N/A
- P/E Ratio
- EARN $6.46
- TVGN N/A
- Revenue Growth
- EARN N/A
- TVGN N/A
- 52 Week Low
- EARN $5.54
- TVGN $0.26
- 52 Week High
- EARN $7.26
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- EARN 48.80
- TVGN 54.34
- Support Level
- EARN $6.53
- TVGN $1.30
- Resistance Level
- EARN $6.82
- TVGN $1.54
- Average True Range (ATR)
- EARN 0.13
- TVGN 0.17
- MACD
- EARN 0.00
- TVGN 0.01
- Stochastic Oscillator
- EARN 40.26
- TVGN 35.14
About EARN Ellington Residential Mortgage REIT of Beneficial Interest
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.